In a study of patients with surgically treated oral cavity carcinomas, Ayala et al. [11] found that patients with high immunohistochemical expression of SLC2A3 had a significantly increased risk of recurrence and decreased survival in both uni- and multivariable analyses. Here, SLC2A3 is linked to oral cavity carcinoma.